Patent · US Active

Antigen-specific immune effector cells

US12163155B2 · kind B2 · utility

0Cited by
26References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2018
Grant dateDec 10, 2024
Priority date
Expiry dateNov 15, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for the production of antigen-specific effector T cells and NK cells from pluripotent stem cells which express a chimeric antigen receptor (CAR). Further provided herein are methods for the adoptive cell therapy by administering the effector T cells and/or NK cells provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.